Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ITH Pharma ApS
APS
Active
CVR 44743167
Øllemosen 7
Business and other management consultancy activities · NACE 7020
Est. 2024
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 285K
EBITDA margin
79.9%
Equity ratio
59.5%
Financial strength
Net profit 2024
DKK 175K
2 employees
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK 285K
—
EBITDA
DKK 228K
—
Net profit
DKK 175K
—
Total assets
DKK 361K
—
Equity
DKK 215K
—
Employees
2
—
Company information
Legal name
ITH Pharma ApS
CVR number
44743167
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
2. april 2024
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Øllemosen 7
Phone
+4561273103
Email
ivanthage@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Sorø
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
285
Staff expenses
-57
EBITDA
228
Depreciation & amort.
-0
EBIT
228
Net financials
-0
Profit before tax
227
Tax
52
Net profit
175
Balance sheet
DKK thousands
Item
2024
Total assets
361
Equity
215
Long-term debt
52
Short-term debt
94
Total debt
146
Financial ratios
5-year trend
EBITDA margin
79.9%
This company
15.8%
Market median
+406% vs market
2024
2024
Equity ratio
59.5%
This company
38.2%
Market median
+56% vs market
2024
2024
Return on equity
81.4%
This company
18.4%
Market median
+342% vs market
2024
2024
Net profit margin
61.4%
This company
8.1%
Market median
+658% vs market
2024
2024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
2024
2024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-04-02 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
IK
Ivan Knud Holmelund Thage
Management
Management
2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ITH Holding ApS
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ITH Holding ApS
ITH Pharma ApS
(this company)
Board network connections
Board members of ITH Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Ivan Knud Holmelund Thage
Management
0 companies